Human papillomavirus 16 (HPV16) enhances tumor growth and cancer stemness of HPV-negative oral/oropharyngeal squamous cell carcinoma cells via miR-181 regulation

Papillomavirus Research

Volumn 1, Issue , 2015, Pages 116-125

  Hee Lee, Sung ^a   Lee, Chang Ryul ^a   Kristina Rigas, Nicole ^a   Kim, Reuben H ^a,b   Kang, Mo K ^a,b   Park, No Hee ^a,b   Shin, Ki Hyuk ^a,b  

^a UCLA SCHOOL OF DENTISTRY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cancer stem cells; HPV; MiR 181; OSCC

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 1; K RAS PROTEIN; MICRORNA; MICRORNA 181A; MICRORNA 181D; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CARCINOMA CELL; CELL ACTIVITY; CELL INVASION; CELL MIGRATION; CELL RENEWAL; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; GENE TARGETING; GENETIC REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MOUSE; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; PAPILLOMAVIRUS INFECTION; PHARYNX CARCINOMA; PHENOTYPE; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA TRANSCRIPTION; VIRUS GENOME; VIRUS VIRULENCE;

EID: 84947907392     PISSN: None     EISSN: 24058521     Source Type: Journal    
DOI: 10.1016/j.pvr.2015.08.001     Document Type: Article

References (50)

1. Al-Swiahb J.N., Chen C.H., Chuang H.C., Fang F.M., Tasi H.T., Chien C.Y. Clinical, pathological and molecular determinants in squamous cell carcinoma of the oral cavity. Futur Oncol. 2010, 6:837-850.
2. Lee C.H., Lee J.M., Wu D.C., Hsu H.K., Kao E.L., Huang H.L., Wang T.N., Huang M.C., Wu M.T. Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan. Int. J. Cancer 2005, 113:475-482.
3. Perez-Sayans M., Somoza-Martin J.M., Barros-Angueira F., Reboiras-Lopez M.D., Gandara Rey J.M., Garcia-Garcia A. Genetic and molecular alterations associated with oral squamous cell cancer (review). Oncol. Rep. 2009, 22:1277-1282.
4. Shiboski C.H., Schmidt B.L., Jordan R.C.K. Tongue and tonsil carcinoma - increasing trends in the US population ages 20-44 years. Cancer 2005, 103:1843-1849.
5. Chaturvedi A.K., Engels E.A., Pfeiffer R.M., Hernandez B.Y., Xiao W.H., Kim E., Jiang B., Goodman M.T., Sibug-Saber M., Cozen W., Liu L.H., Lynch C.F., Wentzensen N., Jordan R.C., Altekruse S., Anderson W.F., Rosenberg P.S., Gillison M.L. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J. Clin. Oncol. 2011, 29:4294-4301.
6. Iype E.M., Pandey M., Mathew A., Thomas G., Sebastian P., Nair M.K. Squamous cell carcinoma of the tongue among young Indian adults. Neoplasia 2001, 3:273-277.
7. Sherin N., Simi T., Shameena P., Sudha S. Changing trends in oral cancer. Indian J. Cancer 2008, 45:93-96.
8. Smith E.M., Ritchie J.M., Summersgill K.F., Hoffman H.T., Wang D.H., Haugen T.H., Turek L.P. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J. Natl. Cancer Inst. 2004, 96:449-455.
9. Hansson B.G., Rosenquist K., Antonsson A., Wennerberg J., Schildt E.B., Bladstrom A., Andersson G. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Oto-Laryngol. 2005, 125:1337-1344.
10. Kellokoski J.K., Syrjanen S.M., Chang F., Yliskoski M., Syrjanen K.J. Southern blot hybridization and PCR in detection of oral human papillomavirus (HPV) infections in women with genital HPV Infections. J. Oral. Pathol. Med. 1992, 21:459-464.
11. Syrjanen S. Viral-infections in oral-mucosa. Scand. J. Dent. Res. 1992, 100:17-31.
12. Beck B., Blanpain C. Unravelling cancer stem cell potential. Nat. Rev. Cancer 2013, 13:727-738.
13. Chiou S.H., Yu C.C., Huang C.Y., Lin S.C., Liu C.J., Tsai T.H., Chou S.H., Chien C.S., Ku H.H., Lo J.F. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin. Cancer Res. 2008, 14:4085-4095.
14. Ginestier C., Hur M.H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., Jacquemier J., Viens P., Kleer C.G., Liu S.L., Schott A., Hayes D., Birnbaum D., Wicha M.S., Dontu G. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1:555-567.
15. Liu S.L., Dontu G., Mantle I.D., Patel S., Ahn N.S., Jackson K.W., Suri P., Wicha M.S. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res. 2006, 66:6063-6071.
16. Giles R.H., van Es J.H., Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochem. Biophys. Acta-Rev. Cancer 1653, 2003:1-24.
17. Evangelista M., Tian H., de Sauvage F.J. The hedgehog signaling pathway in cancer. Clin. Cancer Res. 2006, 12:5924-5928.
18. Leong K.G., Karsan A. Recent insights into the role of Notch signaling in tumorigenesis. Blood 2006, 107:2223-2233.
19. Liu C., Kelnar K., Liu B.G., Chen X., Calhoun-Davis T., Li H.W., Patrawala L., Yan H., Jeter C., Honorio S., Wiggins J.F., Bader A.G., Fagin R., Brown D., Tang D.A.G. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat. Med. 2011, 17. 211-U105.
20. Song S.J., Poliseno L., Song M.S., Ala U., Webster K., Ng C., Beringer G., Brikbak N.J., Yuan X., Cantley L.C., Richardson A.L., Pandolfi P.P. MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell 2013, 154:311-324.
21. Carthew R.W., Sontheimer E.J. Origins and mechanisms of miRNAs and siRNAs. Cell 2009, 136:642-655.
22. Xia H., Hui K.M. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics. Cancer Gene Ther. 2012, 19:723-730.
23. Ke G., Liang L., Yang J.M., Huang X., Han D., Huang S., Zhao Y., Zha R., He X., Wu X. MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene. Oncogene 2013, 32:3019-3027.
24. Yu C.C., Chen Y.W., Chiou G.Y., Tsai L.L., Huang P.I., Chang C.Y., Tseng L.M., Chiou S.H., Yen S.H., Chou M.Y., Chu P.Y., Lo W.L. MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation. Oral Oncol. 2011, 47:202-210.
25. Shi Y., Liu C., Liu X., Tang D.G., Wang J. The microRNA miR-34a inhibits non-small cell lung cancer (NSCLC) growth and the CD44hi stem-like NSCLC cells. PloS One 2014, 9:e90022.
26. Shimono Y., Zabala M., Cho R.W., Lobo N., Dalerba P., Qian D., Diehn M., Liu H., Panula S.P., Chiao E., Dirbas F.M., Somlo G., Pera R.A., Lao K., Clarke M.F. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell 2009, 138:592-603.
27. Wellner U., Schubert J., Burk U.C., Schmalhofer O., Zhu F., Sonntag A., Waldvogel B., Vannier C., Darling D., zur Hausen A., Brunton V.G., Morton J., Sansom O., Schuler J., Stemmler M.P., Herzberger C., Hopt U., Keck T., Brabletz S., Brabletz T. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat. Cell Biol. 2009, 11:1487-1495.
28. Martinez I., Gardiner A.S., Board K.F., Monzon F.A., Edwards R.P., Khan S.A. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 2008, 27:2575-2582.
29. Lajer C.B., Garns E., Friis-Hansen L., Norrild B., Therkildsen M.H., Glud M., Rossing M., Lajer H., Svane D., Skotte L., Specht L., Buchwald C., Nielsen F.C. The role of miRNAs in human papilloma virus (HPV)-associated cancers: bridging between HPV-related head and neck cancer and cervical cancer. Br. J. Cancer 2012, 106:1526-1534.
30. Lin C.J., Grandis J.R., Carey T.E., Gollin S.M., Whiteside T.L., Koch W.M., Ferris R.L., Lai S.Y. Head and neck squamous cell carcinoma cell lines: established models and rationale for selection. Head Neck-J. Sci. Spec. Head Neck 2007, 29:163-188.
31. Park N.H., Min B.M., Li S.L., Huang M.Z., Cherick H.M., Doniger J. Immortalization of normal human oral keratinocytes with type 16 human papillomavirus. Carcinogenesis 1991, 12:1627-1631.
32. Lee S.H., Hong H.S., Liu Z.X., Kim R.H., Kang M.K., Park N.H., Shin K.H. TNFalpha enhances cancer stem cell-like phenotype via Notch-Hes1 activation in oral squamous cell carcinoma cells. Biochem. Biophys. Res. Commun. 2012, 424:58-64.
33. Shin K.H., Bae S.D., Hong H.S., Kim R.H., Kang M.K., Park N.H. miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras. Biochem. Biophys. Res. Commun. 2011, 404:896-902.
34. Zhang M., Kumar B., Piao L., Xie X., Schmitt A., Arradaza N., Cippola M., Old M., Agrawal A., Ozer E., Schuller D.E., Teknos T.N., Pan Q. Elevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma. Cancer 2014, 120:992-1001.
35. Wang X.F., Shi Z.M., Wang X.R., Cao L., Wang Y.Y., Zhang J.X., Yin Y., Luo H., Kang C.S., Liu N., Jiang T., You Y.P. MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2. J. Cancer Res. Clin. 2012, 138:573-584.
36. Shin K.H., Min B.M., Cherrick H.M., Park N.H. , Combined effects of human papillomavirus-18 and N-methyl-N'-nitro-N-nitrosoguanidine on the transformation of normal human oral keratinocytes. Mol. Carcinog. 1994, 9:76-86.
37. Reddout N., Christensen T., Bunnell A., Jensen D., Johnson D., O'Malley S., Kingsley K. High risk HPV types 18 and 16 are potent modulators of oral squamous cell carcinoma phenotypes in vitro. Infect. Agents Cancer 2007, 2:21.
38. Wang S., Pang T.Y., Gao M., Kang H.X., Ding W.B., Sun X.W., Zhao Y., Zhu W., Tang X.D., Yao Y.H., Hu X.R. HPV E6 induces eIF4E transcription to promote the proliferation and migration of cervical cancer. FEBS Lett. 2013, 587:690-697.
39. Liao S.J., Deng D.R., Zhang W.N., Hu X.J., Wang W., Wang H., Lu Y.P., Wang S.X., Meng L., Ma D. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo. Oncol. Rep. 2013, 29:95-102.
40. Yeung C.L.A., Tsang T.Y., Yau P.L., Kwok T.T. Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway. Oncogene 2011, 30:2401-2410.
41. Ranieri D., Belleudi F., Magenta A., Torrisi M.R. , HPV16 E5 expression induces switching from FGFR2b to FGFR2c and epithelial-mesenchymal transition. Int. J. Cancer 2015, 137:61-72.
42. Jung Y.S., Kato I., Kim H.R.C. A novel function of HPV16-E6/E7 in epithelial-mesenchymal transition. Biochem. Biophys. Res. Commun. 2013, 435:339-344.
43. Wald A.I., Hoskins E.E., Wells S.I., Ferris R.L., Khan S.A. Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head Neck 2011, 33:504-512.
44. Martin C.M., Kehoe L., Spillane C.O., O'Leary J.J. Gene discovery in cervical cancer: towards diagnostic and therapeutic biomarkers. Mol. Diagn. Ther. 2007, 11:277-290.
45. Chung C.H., Gillison M.L. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin. Cancer Res. 2009, 15:6758-6762.
46. Mulvany N.J., Allen D.G., Wilson S.M. Diagnostic utility of p16INK4a: a reappraisal of its use in cervical biopsies. Pathology 2008, 40:335-344.
47. Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat. Rev. Cancer 2012, 12:613-626.
48. Caulin C., Nguyen T., Longley M.A., Zhou Z.J., Wang X.J., Roop D.R. Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity. Cancer Res. 2004, 64:5054-5058.
49. Motohara T., Masuko S., Ishimoto T., Yae T., Onishi N., Muraguchi T., Hirao A., Matsuzaki Y., Tashiro H., Katabuchi H., Saya H., Nagano O. Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells. Carcinogenesis 2011, 32:1597-1606.
50. Wang Z.W., Ali S., Banerjee S., Bao B., Li Y.W., Azmi A.S., Korc M., Sarkar F.H. Activated K-Ras and INK4a/Arf deficiency promote aggressiveness of pancreatic cancer by induction of EMT consistent with cancer stem cell phenotype. J. Cell Physiol. 2013, 228:556-562.